SPY412.27-3.80 -0.91%
DIA338.12-3.18 -0.93%
IXIC13,818.41-131.81 -0.94%

BRIEF-Can-Fite Signs $42.7 Mln Out-Licensing Deal With Ewopharma

· 03/16/2021 07:25
BRIEF-Can-Fite Signs $42.7 Mln Out-Licensing Deal With Ewopharma

- Can Fite Biopharma Ltd CANF.TA:

  • CAN-FITE SIGNS $42.7 MILLION OUT-LICENSING DEAL WITH EWOPHARMA

  • CAN FITE BIOPHARMA LTD - SWISS EWOPHARMA TO MARKET PICLIDENOSON AND NAMODENOSON IN CENTRAL EASTERN EUROPE

Source text for Eikon: ID:nBw6tqGyda

Further company coverage: CANF.TA


((Reuters.Briefs@thomsonreuters.com;))